Who owns Acorda Therapeutics?

Key details on Acorda Therapeutics (Ticker: ACOR)

Who owns Acorda Therapeutics?

Is ACOR a good stock to own? Find out who bought Acorda Therapeutics, who sold Acorda Therapeutics (ACOR) stock, and who holds a large position in Acorda Therapeutics.

Fund Name Number of Shares Share Valuation As Of
FMR 6.42M $213.93M June 30, 2015
UBS GLOBAL ASSET MANAGEMENT AMERICAS 3.73M $124.36M June 30, 2015
Vanguard 3.12M $103.80M June 30, 2015
BlackRock Fund Advisors 3.03M $100.86M June 30, 2015
Adage Capital Partners GP 2.71M $64.60M Dec. 31, 2011
Damian Sousa 2.37M $78.99M June 30, 2015
Oracle Investment Management 1.85M $62.71M Sept. 30, 2014
Wellington Management Company 1.78M $59.38M June 30, 2015
Invus Public Equities Advisors 1.70M $54.93M June 30, 2011
STATE STREET CORPORATION 1.62M $53.87M June 30, 2015
Artal Group S.A. 1.50M $49.48M June 30, 2013
Bridger Management 1.50M $39.83M March 31, 2012
GOLDMAN SACHS 1.49M $43.60M Dec. 31, 2013
Ulys 1.30M $34.52M March 31, 2012
Inves 1.25M $47.48M March 31, 2014
BlackRock Institutional Trust Company, N.A. 1.23M $41.52M June 30, 2014
Partner Fund Management 1.23M $41.54M Sept. 30, 2014

Who sold Acorda Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
S.A.C. Capital Advisors June 30, 2011 2.36M $76.31M
Brookside Capital Management, LLC* June 30, 2011 1.39M $44.78M
Wells Fargo & Company March 31, 2011 2.34M $53.62M
Millennium Management March 31, 2011 1.35M $31.36M
Camber Capital Management March 31, 2011 1.25M $29.00M
Westfield Capital Management Company Dec. 31, 2010 1.77M $48.24M
Columbia Wanger Asset Management Sept. 30, 2010 2.06M $68.09M